PCM
MBII

Penserra Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Penserra Capital Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-217,198
Closed -$321K – 1558
2021
Q2 		$321K Sell
217,198
-22,646
-9% -$37.9K 0.01% 564
2021
Q1 		$501K Buy
+239,844
New +$498K 0.01% 446

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penserra Capital Management's MBII Position: Q3 2021 in Review

Penserra Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2021, closing a stake of 217,198 shares — an estimated $321K sold.

Penserra Capital Management first reported a position in MBII in Q1 2021 and held it in 2 quarters. The position peaked at $501K in Q1 2021. 73 funds tracked by Wall St. Rank hold MBII as of Q3 2021.

  • Penserra Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2021 after selling out during the quarter.
  • Penserra Capital Management sold 217,198 Marrone Bio Innovations, Inc. shares in Q3 2021, an estimated $321K.
  • Penserra Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 2 quarters.
  • Penserra Capital Management's Marrone Bio Innovations, Inc. position peaked at $501K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2021.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.